From: The survival and the long-term trends of patients with gastric cancer in Shanghai, China
Stage | Sex | N | Observed survival rate [% (95% CI)] | Relative survival rate [% (95% CI)] | Median survival (years) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 year | 2 years | 3 years | 4 years | 5 years | 1 year | 2 years | 3 years | 4 years | 5 years | ||||
I | Male | 394 | 88 (84–91) | 80 (76–84) | 73 (68–77) | 69 (64–73) | 68 (63–73) | 91 (88–94) | 85 (81–88) | 83 (79–87) | 84 (80–88) | 88 (85–91) | >5 |
Female | 207 | 90 (85–94) | 80 (74–85) | 74 (67–80) | 71 (64–77) | 67 (60–73) | 93 (89–96) | 85 (79–90) | 81 (75–86) | 82 (76–87) | 81 (75–86) | >5 | |
II | Male | 721 | 79 (76–82) | 64 (60–67) | 55 (51–59) | 51 (47–55) | 48 (44–52) | 81 (78–84) | 69 (65–72) | 63 (59–67) | 63 (59–67) | 64 (60–68) | 4.38 |
Female | 364 | 78 (73–82) | 66 (61–71) | 58 (53–63) | 53 (48–58) | 50 (45–55) | 81 (77–85) | 70 (65–75) | 64 (59–69) | 61 (56–66) | 61 (56–66) | 4.91 | |
III | Male | 902 | 59 (56–62) | 41 (38–44) | 31 (28–34) | 27 (24–30) | 25 (22–28) | 62 (59–65) | 45 (42–48) | 36 (33–39) | 34 (31–37) | 35 (32–38) | 1.51 |
Female | 451 | 62 (57–66) | 42 (37–47) | 35 (31–40) | 31 (27–36) | 29 (25–33) | 64 (60–69) | 44 (39–49) | 39 (35–44) | 36 (32–41) | 36 (32–41) | 1.58 | |
IV | Male | 982 | 27 (24–30) | 15 (13–17) | 11 (9–13) | 8 (6–10) | 7 (6–9) | 29 (26–32) | 17 (15–20) | 13 (11–15) | 11 (9–13) | 10 (8–12) | 0.68 |
Female | 522 | 28 (24–32) | 15 (12–18) | 11 (9–14) | 9 (7–12) | 8 (6–11) | 29 (25–33) | 17 (14–21) | 13 (10–16) | 11 (8–14) | 10 (8–13) | 0.69 | |
Unknown | Male | 4039 | 46 (44–48) | 32 (31–33) | 26 (25–27) | 23 (22–24) | 21 (20–22) | 50 (49–52) | 37 (36–39) | 33 (32–35) | 33 (32–35) | 34 (33–36) | 0.93 |
Female | 2327 | 48 (46–50) | 34 (32–36) | 29 (27–31) | 27 (25–29) | 24 (22–26) | 54 (52–56) | 40 (38–42) | 36 (34–38) | 36 (34–38) | 36 (34–38) | 0.96 |